US Stock MarketDetailed Quotes

SANA Sana Biotechnology

Watchlist
  • 9.000
  • -0.080-0.88%
Close Apr 30 16:00 ET
  • 9.000
  • 0.0000.00%
Post 17:11 ET
1.99BMarket Cap-6164P/E (TTM)

About Sana Biotechnology Company

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.

Company Profile

SymbolSANA
Company NameSana Biotechnology
Listing DateFeb 4, 2021
Issue Price25.00
Founded2018
CEODr. Steven D. Harr, M.D.
MarketNASDAQ
Employees328
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address188 East Blaine Street,Suite 400
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98102
Phone1-206-701-7914
Websitehttp://www.sana.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Steven D. Harr, M.D.
  • President, Chief Executive Officer and Director
  • 3.81M
  • Dr. Gary Meininger, M.D.
  • Chief Medical Officer
  • --
  • Christian Hordo
  • Executive Vice President and Chief Business Officer
  • --
  • Nathan Hardy
  • Principal Accounting Officer, Executive Vice President and Chief Financial Officer
  • --
  • Bernard J. Cassidy
  • Executive Vice President, General Counsel and Corporate Secretary
  • 3.95M
  • Dr. Richard C. Mulligan, PhD
  • Executive Vice Chairman of the Board and Head of SanaX
  • --
  • Hans Edgar Bishop
  • Chairman of the Board
  • 300.00K
  • Mary Agnes Wilderotter
  • Independent Director
  • 260.00K
  • Dr. Patrick Y. Yang, PhD
  • Independent Director
  • 245.00K
  • Robert Taylor Nelsen
  • Independent Director
  • 240.00K
  • Dr. Joshua H. Bilenker, M.D.
  • Independent Director
  • 245.00K
  • Dr. Douglas G. Cole, M.D.
  • Independent Director
  • 247.50K
  • Michelle Seitz, C.F.A.
  • Independent Director
  • 260.00K
  • Dr. Alise S. Reicin, M.D.
  • Independent Director
  • 247.50K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg